Literature DB >> 32789265

Using Physical Function to Predict Hospital Readmission within 1 Year in Patients with Heart Failure.

Hiroaki Teramatsu1, Junichiro Shiraishi2, Yasuyuki Matsushima2, Masaru Araki3, Tetsuya Okazaki4, Satoru Saeki2.   

Abstract

OBJECTIVE: The aim of this study was to investigate which method of evaluating physical function could predict 1-year readmission due to worsening of heart failure (HF) in newly diagnosed HF patients.
METHODS: One hundred sixteen consecutive patients with HF who underwent cardiac rehabilitation at our hospital between May 2012 and September 2015 were retrospectively enrolled. Participants were divided into two groups based on whether they were readmitted for worsening HF within 1 year. Logistic regression analysis was used to evaluate whether physical function at the time of discharge was related to HF readmission within 1 year.
RESULTS: After a mean follow-up period of 327 days, 22 patients were readmitted because of worsening HF. In the readmission group, the results of the 6-Minute Walk Test (6MWT), One-Leg Standing Test, and 30-Second Chair-Stand Test at initial discharge were significantly worse than those in the non-readmission group. In a multivariable logistic regression model, after adjusting for age and sex, a lower 6MWT distance was independently associated with increased risk of readmission within 1 year (odds ratio: 0.990, 95% confidence interval: 0.985-0.996). The 6MWT showed better prognostic value (area under the receiver operating characteristic curve: 0.696) than other evaluation methods of physical function. The 1-year non-readmission rates were 90% for 6MWT ≥382.5 m, 68% for 6MWT <382.5 m, and 53% for those unable to walk 200 m independently (P <0.001).
CONCLUSION: Physical function, particularly the 6MWT distance at time of discharge, can be used to predict the likelihood of readmission within 1 year for patients with HF. ©2019 The Japanese Association of Rehabilitation Medicine.

Entities:  

Keywords:  1-year readmission; 6-minute walk test; heart failure; physical function

Year:  2019        PMID: 32789265      PMCID: PMC7365195          DOI: 10.2490/prm.20190018

Source DB:  PubMed          Journal:  Prog Rehabil Med        ISSN: 2432-1354


  47 in total

1.  Functional reach: predictive validity in a sample of elderly male veterans.

Authors:  P W Duncan; S Studenski; J Chandler; B Prescott
Journal:  J Gerontol       Date:  1992-05

2.  Hospital strategies to reduce heart failure readmissions: where is the evidence?

Authors:  Javed Butler; Andreas Kalogeropoulos
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

3.  Exercise Capacity and Functional Performance in Heart Failure Patients Supported by a Left Ventricular Assist Device at Discharge From Inpatient Rehabilitation.

Authors:  Thomas Schmidt; Birna Bjarnason-Wehrens; Petra Bartsch; Ezin Deniz; Jan Schmitto; Sebastian Schulte-Eistrup; Detlev Willemsen; Nils Reiss
Journal:  Artif Organs       Date:  2017-06-16       Impact factor: 3.094

4.  A 30-s chair-stand test as a measure of lower body strength in community-residing older adults.

Authors:  C J Jones; R E Rikli; W C Beam
Journal:  Res Q Exerc Sport       Date:  1999-06       Impact factor: 2.500

5.  Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?

Authors:  G Roul; P Germain; P Bareiss
Journal:  Am Heart J       Date:  1998-09       Impact factor: 4.749

6.  Functional limitations predict the risk of rehospitalization among patients with chronic heart failure.

Authors:  Sumio Yamada; Yuko Shimizu; Makoto Suzuki; Tohru Izumi
Journal:  Circ J       Date:  2012-04-07       Impact factor: 2.993

7.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

Authors:  James C Fang; Gregory A Ewald; Larry A Allen; Javed Butler; Cheryl A Westlake Canary; Monica Colvin-Adams; Michael G Dickinson; Phillip Levy; Wendy Gattis Stough; Nancy K Sweitzer; John R Teerlink; David J Whellan; Nancy M Albert; Rajan Krishnamani; Michael W Rich; Mary N Walsh; Mark R Bonnell; Peter E Carson; Michael C Chan; Daniel L Dries; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Stephanie Moore; Jo E Rodgers; Joseph G Rogers; Amanda R Vest; Michael M Givertz
Journal:  J Card Fail       Date:  2015-05-04       Impact factor: 5.712

Review 8.  Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.

Authors:  Marco Metra; Piotr Ponikowski; Kenneth Dickstein; John J V McMurray; Antonello Gavazzi; Claes-Hakan Bergh; Alan G Fraser; Tiny Jaarsma; Antonis Pitsis; Paul Mohacsi; Michael Böhm; Stefan Anker; Henry Dargie; Dirk Brutsaert; Michel Komajda
Journal:  Eur J Heart Fail       Date:  2007-05-03       Impact factor: 15.534

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

10.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.